The Women's Health Initiative: A heart-to-HRT conversation

Mayo Clinic Proceedings

Volumn 75, Issue 6, 2000, Pages 559-561

  Fitzpatrick, L A ^a   Litin, S C ^a   Bell, M R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; EDITORIAL; HORMONAL REGULATION; HORMONE SUBSTITUTION; OSTEOPOROSIS; POSTMENOPAUSE; RISK BENEFIT ANALYSIS; SUBSTITUTION THERAPY;

EID: 0034094470     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.6.559     Document Type: Editorial

References (27)

1. National Heart, Lung, and Blood Institute National Inslilutes of Health. Women's Health Initiative Available at: www.nhlbi.nih.gov/whi/index.html Accessed May 10, 2000.
2. HJ Grodslein MJ Slampfer GA Colditz Postmenopausal hormone therapy and mortality N Engl J Med 336 1997 1769 1775
3. GA Colditz SE Hankinson DJ Hunter The use of estrogens and progeslins and the risk of breast cancer in postmenopausal women N Engl J Med 332 1995 1589 1593
4. TA Sellers PJ Mink JR Cerhan The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer Ann Intern Med 127 1997 973 980
5. JI Stanford NS Weiss L Voigt JR Daling LA Habel MA Rossing Combined estrogen and progestin hormone replacement therapy in elation to risk of breast cancer in middle-aged women JAMA 274 1995 137 142
6. B Henderson A Paganini TIill RK Ross Decreased mortality in users of estrogen replacement therapy Arch intern Med 151 1991 75 78
7. Collaborative Group on Hormonal Factors in Breast Cancer Breast cance and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52.705 women with breast cancer and 108.411 women without breast cance [published correction appears in Lancet. 1997:350:14841 Lancet 350 1997 1047 1059
8. C Schairer J Lubin R Troisi S Sturgeon L Brinton R Hoover Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk JAMA 283 2000 485 491
9. TL Bush MK Whiteman Hormone replacement therapy and risk of breast cancer [editorial] JAMA 281 1999 2140 2141
10. G Guyat J Sinclair DJ Cook P Glasjiou Evidence-Based Medicine Working Group and Cochrane Applicability Methods Working Group Users' guides to the medical literature. XVI: how to use a treatment recommendation JAMA 281 1999 1836 1843
11. NT Col SG Pauker RJ Goldberg Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women Arch Intern Med 159 1999 1458 1466
12. Premarin [package insert] 2000 Wyelh-Ayerst Pharmaceuticals Philadelphia, Pa
13. T Bush Noncontraceptive eslrogen use and risk of card iovascular disease: an overview and critique of the literature SG Korenman The Menopause: Biological and Clinical Consequences of Ovarian Failure: Evolution and Management 1990 Serono Symposia Norwell, Mass 211 223
14. MD Mendelsohn RH Karas The protective effects of estrogen on the cardiovascular system N Engl J Med 340 1999 1801 1811
15. AP van Beek FC de Ruijter-Heijstek DW Erkelens TW de Bruin Menopause is associated with reduced protection from postprandial Ypcmd Arienoscler Thromb Vasc Biol 19 1999 2737 2741
16. KK Koh C Cardillo MN Bui Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women Circulation 99 1999 354 360
17. EM Aygen M Bashug M Eayyar U Kaya The effects of different doses of medroxyprogesterone acetate on serum lipids. lipoprolein levels and alheroaenic index in the menopausal period Gynecol Endocrinol 2 1998 267 272
18. UK Genant J Lucas S Weiss Estratab/Osteoporosis Study Group. Low-dose eslerified estrogen therapy: effects on bone. plasma estradiol concentrations, endomelrium, and lipid levels Arch Intern Med 157 1997 2609 2615
19. HC Bucher GH Guyatt DJ Cook A Holbrook FA McAlister Evidence-Based Medicine Working Group Users' guides to the medical literature, XIX: applying clinical trial results. A: how to use an article measuring the effect of an intervention on surrogate end poises JAMA 282 1999 771 778
20. S Hulley D Grady T Bush Heart and Hstrogen/progestin Replacement Study (HIERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613
21. D Grady NK Wenger D Herrington Heart and Estrogen/progestin Replacement Study. Postmenopausal hormone therapy increases risk for venous thromboembolic disease Ann InternMed 132 2000 689 696
22. C Lentant Preliminary trends in the Women's Health Initiative Epress release] April 3, 2000 National Heart. Lung, and Blood Institute Bethesda, Md
23. Wake Forest University Baptist Medical Center Computerized analysis of heart arteries shows no benefits of hormone therapy Available at: www.wfulimc.edu/csa-hin/new.sLdit2/MewArchiveStory.cgi?article=95297I121 Accessed May 10. 2000.
24. JG Meisler Office of Research on Women's Health Seminar Series-Part I: finding the answers on hormone replacement therapy J Womens Health 8 1999 51 57
25. A Nasr M Breckwoldt Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg Gynecol Endocrinol 12 1998 43 59
26. S Oparil C Arthur Corcoran Memorial lecture: hormones and vasoproteclion Hypertension 33 1999 170 176
27. E Barrett-Connor NK Wenger D Grady Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene J Womens Health 7 1998 839 847